Allakos (ALLK) Stock Chart & Stock Price History $0.33 0.00 (0.00%) As of 05/15/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Allakos Stock Price Performance The Allakos (ALLK) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 73.46%, with a year-to-date return of -72.80%. In the past month, the stock has decreased 0.06%, reflecting recent market activity. As of the latest close, Allakos traded at $0.33 with a market cap of $29.74 million and volume of 0 shares. Five years ago, the stock traded at $67.80, representing a 99.51% decrease over that period. At the time, it had a market cap of $3.57 billion and a volume of 253,451 shares. Receive ALLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance-0.06%3 Month Performance+31.64%Year-To-Date Performance-72.80%1 Year Performance-73.46%5 Year Performance-99.51% ALLK Stock Chart for Friday, June, 13, 2025 ALLK Chart by TradingView Allakos Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2025$0.33$0.33$0.33$0.33725,800 shs$29.74 million05/14/2025$0.33$0.33-0.06%$0.33$0.33725,550 shs$29.74 million05/13/2025$0.33$0.33-0.09%$0.33$0.33439,711 shs$29.76 million05/12/2025$0.33$0.33+0.33%$0.33$0.33632,717 shs$29.79 million Related Companies Atossa Therapeutics Stock Chart Caribou Biosciences Stock Chart Exozymes Stock Chart Cardiol Therapeutics Stock Chart Invivyd Stock Chart Contineum Therapeutics Stock Chart BioHarvest Sciences Stock Chart Corbus Pharmaceuticals Stock Chart Tenaya Therapeutics Stock Chart Anixa Biosciences Stock Chart Receive ALLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALLK) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allakos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allakos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.